# reload+after+2024-01-21 18:46:09.302981
address1§855 North Wolfe Street
address2§Suite 601
city§Baltimore
state§MD
zip§21205
country§United States
phone§856 848 8698
website§https://www.mymd.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic analog of cannabidiol for treating epilepsy, pain, and anxiety/depression. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
fullTimeEmployees§10
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Christopher C. Chapman Jr., M.D.', 'age': 70, 'title': 'President, Chief Medical Officer & Director', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 261827, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Adam  Kaplin M.D., Ph.D.', 'age': 56, 'title': 'Chief Scientific Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 353733, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ian  Rhodes CPA', 'age': 50, 'title': 'Interim Chief Financial Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jenna  Brager M.S., Ph.D., R.N.', 'title': 'Executive Vice President of Drug Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§3.487
currency§USD
dateShortInterest§1702598400
exchange§NCM
quoteType§EQUITY
shortName§MyMD Pharmaceuticals, Inc.
longName§MyMD Pharmaceuticals, Inc.
firstTradeDateEpochUtc§1390487400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§34173f06-54fb-3bb0-ac22-953c9b18b337
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§1.488
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
